Cardiogen (20mg)
Cardiac Peptide Bioregulator
Cardiogen is a synthetic peptide bioregulator developed from extracts of the cardiac muscle, designed to support healthy heart tissue function, cellular regeneration, and cardiovascular resilience.
The Science
What is Cardiogen?
Cardiogen belongs to the family of short peptide bioregulators researched extensively in Russia by Khavinson and colleagues. These tissue-specific peptides are thought to regulate gene expression in their target organ.
Cardiogen targets cardiac tissue, supporting the synthesis of structural and functional proteins in cardiomyocytes and contributing to healthy myocardial function.
It is studied as a peptide bioregulator for age-related cardiovascular decline and tissue maintenance.
Laboratory Observations
Key Observed Effects of Cardiogen (20mg)
Heart Tissue Support
Targets cardiac cells specifically for tissue maintenance.
Cellular Renewal
Supports normal cellular turnover in heart muscle.
Bioregulator Action
Operates through gene expression rather than receptor agonism.
Mechanism of Action
Mechanism of Action
Cardiogen acts as a tissue-specific bioregulator influencing cardiac cell gene expression.
Tissue-Specific Regulation
Targets cardiomyocyte gene expression to support healthy protein synthesis in heart tissue.
Cellular Renewal
Supports cellular turnover and repair processes in the myocardium.
Cardiovascular Resilience
Helps maintain functional capacity of the heart muscle through aging.
Research-Only Notice
Cardiogen (20mg) is categorized by the FDA as for research-purposes-only. It is not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. The information above summarizes effects observed in laboratory studies to date and is provided strictly for scientific and educational reference.